Dopaminergic modulation of positive expectations for goal-directed action: evidence from Parkinson’s disease
暂无分享,去创建一个
[1] John R Hodges,et al. The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening , 2006, International journal of geriatric psychiatry.
[2] H. Bergman,et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease , 2010, Nature Reviews Neuroscience.
[3] D. Eckstein,et al. Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition , 2008, Brain : a journal of neurology.
[4] Catalin V. Buhusi,et al. What makes us tick? Functional and neural mechanisms of interval timing , 2005, Nature Reviews Neuroscience.
[5] Roger A. Barker,et al. Dynamic causal modelling of effective connectivity from fMRI: Are results reproducible and sensitive to Parkinson's disease and its treatment? , 2010, NeuroImage.
[6] M. D’Esposito,et al. Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.
[7] F. Horak,et al. Step initiation in Parkinson's disease: Influence of levodopa and external sensory triggers , 1997, Movement disorders : official journal of the Movement Disorder Society.
[8] P. O'Suilleabhain,et al. Proprioception in Parkinson's disease is acutely depressed by dopaminergic medications , 2001, Journal of Neurology Neurosurgery & Psychiatry.
[9] Karl J. Friston,et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.
[10] C. Marsden,et al. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.
[11] M. Borutta,et al. A defect of kinesthesia in Parkinson's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.
[12] E. Phelps,et al. Neural mechanisms mediating optimism bias , 2007, Nature.
[13] R. Barker,et al. Parkinson's disease and healthy aging: Independent and interacting effects on action selection , 2010, Human brain mapping.
[14] Konrad Paul Kording,et al. Bayesian integration in sensorimotor learning , 2004, Nature.
[15] A. Raftery. Bayesian Model Selection in Social Research , 1995 .
[16] M. Jahanshahi,et al. Time estimation and reproduction is abnormal in Parkinson's disease. , 1992, Brain : a journal of neurology.
[17] Howard Poizner,et al. Impaired Endogenously Evoked Automated Reaching in Parkinson's Disease , 2011, The Journal of Neuroscience.
[18] David J. Brooks,et al. Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study , 2014, Brain : a journal of neurology.
[19] C D Marsden,et al. Depression in Parkinson's disease: a quantitative and qualitative analysis. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[20] Shelley E. Taylor,et al. Illusion and well-being: a social psychological perspective on mental health. , 1988, Psychological bulletin.
[21] L. Abramson,et al. Depressive realism: Four theoretical perspectives. , 1988 .
[22] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[23] P. Petrovic,et al. Believing is seeing: expectations alter visual awareness , 2008, Current Biology.
[24] J. Konczak,et al. The effect of dopamine replacement therapy on haptic sensitivity in Parkinson’s disease , 2010, Journal of Neurology.
[25] R. Dolan,et al. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans , 2006, Nature.
[26] P. Cardoso-Leite,et al. Neuroscience and Biobehavioral Reviews Action effect anticipation: Neurophysiological basis and functional consequences (cid:2) , 2022 .
[27] H. Shibasaki,et al. Oculomotor abnormalities in Parkinson's disease. , 1979, Archives of neurology.
[28] R. Cools. Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease , 2006, Neuroscience & Biobehavioral Reviews.
[29] T. Flash,et al. Kinematic analysis of upper limb trajectories in Parkinson's disease , 1992, Experimental Neurology.
[30] T. Robbins,et al. Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease , 2007, The Journal of Neuroscience.
[31] P. Haggard,et al. Voluntary action and conscious awareness , 2002, Nature Neuroscience.
[32] Roger A. Barker,et al. Perseveration and Choice in Parkinson's Disease: The Impact of Progressive Frontostriatal Dysfunction on Action Decisions , 2012, Cerebral cortex.
[33] D H Brainard,et al. The Psychophysics Toolbox. , 1997, Spatial vision.
[34] M Schulzer,et al. Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease , 2001, Science.
[35] D. Wolpert,et al. Abnormalities in the awareness and control of action. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[36] Marjan Jahanshahi,et al. What contributes to quality of life in patients with Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[37] E. Nestler,et al. Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.
[38] C. Clarke,et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[39] Monica Gori,et al. Parkinson's disease accelerates age-related decline in haptic perception by altering somatosensory integration. , 2012, Brain : a journal of neurology.
[40] M. Merello,et al. Addenbrooke’s Cognitive Examination validation in Parkinson’s disease , 2009, European journal of neurology.
[41] T. Robbins,et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.
[42] Luis F. Schettino,et al. Hand preshaping in Parkinson’s disease: effects of visual feedback and medication state , 2005, Experimental Brain Research.
[43] David M. Ludlum. An Uneven Pattern , 1984 .
[44] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[45] Emily Balcetis,et al. See what you want to see: motivational influences on visual perception. , 2006, Journal of personality and social psychology.
[46] R. Carpenter,et al. Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity , 2011, Neurobiology of Disease.
[47] Angie A. Kehagia,et al. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.
[48] Stanley Fahn,et al. Levodopa: 50 years of a revolutionary drug for Parkinson disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[49] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[50] J. Nutt,et al. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease , 1995, Neurology.
[51] M. B. Bender,et al. Oculomotor function in patients with Parkinson's disease. , 1972, Journal of the neurological sciences.
[52] J. Rowe,et al. Beyond the “urge to move”: objective measures for the study of agency in the post-Libet era , 2014, Front. Hum. Neurosci..
[53] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[54] Hartwig R. Siebner,et al. Cue integration and the perception of action in intentional binding , 2013, Experimental Brain Research.
[55] R. Dolan,et al. Dopamine Enhances Expectation of Pleasure in Humans , 2009, Current Biology.
[56] Zoubin Ghahramani,et al. Computational principles of movement neuroscience , 2000, Nature Neuroscience.
[57] D. Wolpert,et al. Seeing what you want to see: priors for one's own actions represent exaggerated expectations of success , 2014, Front. Behav. Neurosci..
[58] H. Vankova. Mini Mental State , 2010 .
[59] Mark Hallett,et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors , 2009, Psychopharmacology.
[60] A. Grace,et al. Linking neuroscience with modern concepts of impulse control disorders in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[61] J. Dichgans,et al. Visual control of arm movement in Parkinson's disease , 1994, Movement disorders : official journal of the Movement Disorder Society.
[62] Michael I. Jordan,et al. Computational models of sensorimotor integration , 1997 .
[63] T. Robbins,et al. The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study. , 2012, Brain : a journal of neurology.
[64] B. Amblard,et al. Increased Visual Dependence in Parkinson's Disease , 2002, Perceptual and motor skills.
[65] William E. S. McNeill. Seeing what you want , 2015, Consciousness and Cognition.
[66] Brent L. Hughes,et al. Neural systems of social comparison and the “above-average” effect , 2010, NeuroImage.
[67] Jean-Philippe Azulay,et al. Influence of visual cues on gait in Parkinson's disease: Contribution to attention or sensory dependence? , 2006, Journal of the Neurological Sciences.
[68] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[69] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[70] Patrick Haggard,et al. Dopaminergic medication boosts action–effect binding in Parkinson's disease , 2010, Neuropsychologia.
[71] B. Dubois,et al. Motivation, reward, and Parkinson’s disease: influence of dopatherapy , 2002, Neuropsychologia.
[72] C. Marsden,et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. , 1992, Brain : a journal of neurology.